Chemoinformaics analysis of Methyl 2,4-dihydroxy-3,5,6-trimethylbenzoate
| Molecular Weight | 210.229 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.117 | nRig | 7 |
| Exact Molecular Weight | 210.089 | nRing | 1 |
| Solubility: LogS | -2.526 | nHRing | 0 |
| Solubility: LogP | 2.867 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 30.9131 |
| nHD | 2 | BPOL | 16.6489 |
| QED | 0.694 |
| Synth | 2.295 |
| Natural Product Likeliness | 0.987 |
| NR-PPAR-gamma | 0.212 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.006 |
| HIA | 0.017 |
| CACO-2 | -4.74 |
| MDCK | 0.0000166 |
| BBB | 0.296 |
| PPB | 0.968366 |
| VDSS | 0.548 |
| FU | 0.0288514 |
| CYP1A2-inh | 0.914 |
| CYP1A2-sub | 0.951 |
| CYP2c19-inh | 0.15 |
| CYP2c19-sub | 0.733 |
| CYP2c9-inh | 0.193 |
| CYP2c9-sub | 0.675 |
| CYP2d6-inh | 0.1 |
| CYP2d6-sub | 0.378 |
| CYP3a4-inh | 0.161 |
| CYP3a4-sub | 0.216 |
| CL | 14.399 |
| T12 | 0.818 |
| hERG | 0.007 |
| Ames | 0.103 |
| ROA | 0.075 |
| SkinSen | 0.664 |
| Carcinogencity | 0.066 |
| EI | 0.949 |
| Respiratory | 0.208 |
| NR-Aromatase | 0.306 |
| Antiviral | No |
| Prediction | 0.701949 |